Technical Support
(877) SEPAX-US, press 3 TechSupport@sepax-tech.com |
|
Search Results
Application
Literature Reference: Novel Thienoduocarmycin-trastuzumab ADC Demonstrates Strong Anti-tumor Efficacy - View application note |
MAb/ADC Fragment Separation after IDeS Digestion - View application note |
Intact MAb, ADC and their Fragments Analysis on RP LC/MS - View application note |
MAb Loading from Analytical to Prep HIC - View application note |
MAb hydrophobicity screening on Proteomix HIC Butyl-NP5 - View application note |
Erbitux and Rituximab Monoclonal Antibody Separation on Proteomix HIC Butyl NP5 - View application note |
HICP1001 - Fusion protein Analysis on Proteomix® HICBu-NP5 ( 4603 ) - View application note |
Analytical Characterization of Monoclonal Antibody IgG2 - View application note |
Analytical Characterization of NIST MAb by Hydrophobic Interaction Chromatography (HIC) - View application note |
Analytical Characterization of NIST MAb by Sepax SEC, HIC, RP and CEX - View application note |
Literature Reference: Design and Characterization of Homogenous Antibody-drug Conjugates with a Drug-to-Antibody Ratio of One Prepared Using an Engineered Antibody and a Dual-maleimide Pyrrolobenzodiazepine Dimer - View application note |